Cynata Therapeutics talks stem cell research at Proactive’s CEO Sessions – Proactive Investors Australia
Proactive Investors Australia |
Cynata Therapeutics talks stem cell research at Proactive's CEO Sessions
Proactive Investors Australia The technology addresses a critical shortcoming in existing methods of production of mesenchymal stem cells (MSCs) for therapeutic use. Cynata is now in a transition to a clinical stage company. Earlier this year Cynata announced a breakthrough … |
